RPL7AP73

Across TCGA pan-cancer cohorts, RPL7AP73 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL7AP73 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RPL7AP73 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7AP73 expression acts as an unfavorable survival marker, although some lineages such as UCS and THYM show a favorable association.

LUAD, ACC, and MESO are the cancer types where RPL7AP73 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	III,IV	0.283	0.558	.001	79	view →
ACC	DFS	Median	All	0.520	0.897	<.001	51	view →
MESO	OS	Tertile	IV	0.115	0.671	<.001	46	view →
BRCA	DFS	Quartile	IV	0.249	0.661	.002	27	view →
KICH	DFS	Tertile	All	0.584	0.948	.007	21	view →
UCS	DFS	Median	IV	0.885	0.440	.015	18	view →
BLCA	OS	Quartile	III,IV	0.216	0.396	.002	18	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.595	.017	14	view →
STAD	OS	Tertile	III,IV	0.207	0.439	.022	13	view →
UCEC	OS	Quartile	IV	0.240	0.653	<.001	12	view →
KIRC	DFS	Median	IV	0.534	0.686	.011	9	view →
COAD	DFS	Median	III,IV	0.557	0.710	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL7AP73–LUAD (DFS)

Open the LUAD breakdown →